SOLVAY PHARMACEUTICALS INC has a total of 21 patent applications. Its first patent ever was published in 2001. It filed its patents most often in United States, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are AJAMI ALFRED M, METABOLIC SOLUTIONS DEV CO and LILLY ICOS LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 9 | |
#2 | Canada | 4 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Agriculture | |
#5 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Animal care | |
#5 | Peptides | |
#6 | Measuring volume |
# | Name | Total Patents |
---|---|---|
#1 | Caras Steven David | 6 |
#2 | Van Der Hoop Roland Gerritsen | 4 |
#3 | Kruse Cornelis G | 3 |
#4 | Zumbrunnen Troy | 3 |
#5 | Dubash Darius D | 2 |
#6 | Berger Claudia | 2 |
#7 | Clark Bradley A | 2 |
#8 | Nys Guy | 2 |
#9 | Loeken Christiane | 2 |
#10 | Deleersnijder Willy | 2 |
Publication | Filing date | Title |
---|---|---|
EP2044943A1 | Pharmaceutical compositions comprising esterified estrogens and methyltestosterone and method of using the same | |
WO2006091903A1 | Method of treatment of diarrhea-predominant irritable bowel syndrome in a subject | |
WO2006093774A2 | Method of treatment of diarrhea-predominant ibs in a female subject receiving contraceptive therapy | |
US7435738B2 | Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate) | |
CA2501846A1 | Therapeutic combinations for the treatment of hormone deficiencies | |
CA2451725A1 | Therapeutic combinations for the treatment of hormone deficiencies | |
US6702155B1 | Metered dose dispenser |